ANTIVIRAL DRUG RESISTANCE IN HUMAN CYTOMEGALOVIRUS

Project: Research project

StatusFinished
Effective start/end date5/1/961/31/15

Funding

  • National Institutes of Health: $339,605.00
  • National Institutes of Health: $264,250.00
  • National Institutes of Health: $264,250.00
  • National Institutes of Health: $252,000.00
  • National Institutes of Health: $222,442.00
  • National Institutes of Health
  • National Institutes of Health
  • National Institutes of Health: $346,500.00
  • National Institutes of Health: $238,941.00
  • National Institutes of Health: $264,250.00
  • National Institutes of Health: $261,188.00
  • National Institutes of Health: $343,035.00
  • National Institutes of Health: $252,000.00
  • National Institutes of Health: $246,078.00
  • National Institutes of Health: $207,599.00
  • National Institutes of Health: $339,605.00

Fingerprint

Viral Drug Resistance
Cytomegalovirus
Mutation
Pharmaceutical Preparations
Antiviral Agents
Phosphotransferases
Drug Resistance
Foscarnet
Ganciclovir
Cytomegalovirus Infections
DNA-Directed DNA Polymerase
Immunocompromised Host
Therapeutics

ASJC

  • Medicine(all)
  • Immunology and Microbiology(all)